Trial of pramipexole for depression in PD


A new study reports that the dopamine agonist pramipexole appears to have direct antidepressant effects in Parkinson’s disease patients with comorbid depression (Bxarone et al. Lancet Neurol 2010; 9: 573-580).

It takes 30 seconds

Recommend to a Colleague

Related Posts

Go back to home page